Target intelligence / Profile preview

Ribosomal protein L7a pseudogene 47 (RPL7AP47)

Target: RPL7AP47
Molecular classification: Other (pseudogene)

Overview

Ribosomal protein L7a pseudogene 47 (RPL7AP47) is a processed pseudogene originating from the functional ribosomal protein L7a gene (RPL7A). Pseudogenes like RPL7AP47 lack the ability to encode functional proteins due to accumulated disabling mutations and are not known to be transcribed or play direct functional roles in human biology, disease, or as drug targets. RPL7AP47 shares sequence similarity with the parent gene but does not produce a protein product and is not considered a therapeutic target or relevant for biomarker or drug interactions[1][2][11][13][14].

Other names: RPL7A_13_964RPL7AP47ribosomal protein L7a pseudogene 47

Beyond the preview

Go deeper on Ribosomal protein L7a pseudogene 47 (RPL7AP47).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7a pseudogene 47 (RPL7AP47).

Explore the full profile